UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

Identification and Characterization of New Chemical Entities Targeting Apurinic/Apyrimidinic Endonuclease 1 for the Prevention of Chemotherapy-Induced Peripheral Neuropathy

The Journal of pharmacology and experimental therapeutics, 2016-11, Vol.359 (2), p.300

2016

Link zum Volltext

Verfügbarkeit prüfen

New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types

Pharmacological research, 2024-03, Vol.201, p.107092-107092, Article 107092

2024

Link zum Volltext

Verfügbarkeit prüfen

Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel

The Journal of pharmacology and experimental therapeutics, 2002-05, Vol.301 (2), p.427

2002

Link zum Volltext

Verfügbarkeit prüfen

Influence of Molecular Structure on Substrate Binding to the Human Organic Cation Transporter, hOCT1

Molecular pharmacology, 2003-03, Vol.63 (3), p.489-498

2003

Link zum Volltext

Verfügbarkeit prüfen

Application of Three-Dimensional Quantitative Structure-Activity Relationships of P-Glycoprotein Inhibitors and Substrates

Molecular pharmacology, 2002-05, Vol.61 (5), p.974-981

2002

Link zum Volltext

Verfügbarkeit prüfen

Three-Dimensional Quantitative Structure-Activity Relationships of Inhibitors of P-Glycoprotein

Molecular pharmacology, 2002-05, Vol.61 (5), p.964-973

2002

Link zum Volltext

Verfügbarkeit prüfen

Progress in predicting human ADME parameters in silico

Journal of pharmacological and toxicological methods, 2000-07, Vol.44 (1), p.251-272

2000

Link zum Volltext

Verfügbarkeit prüfen

Biodistribution Study of Dibenzazepine-loaded Polymeric Nanoparticles in Sprague Dawley Rats

Obesity (Silver Spring, Md.), 2022-11, Vol.30, p.186-186

2022

Link zum Volltext

Verfügbarkeit prüfen

Three-dimensional-quantitative structure activity relationship analysis of cytochrome P-450 3A4 substrates

The Journal of pharmacology and experimental therapeutics, 1999-10, Vol.291 (1), p.424

1999

Link zum Volltext

Verfügbarkeit prüfen

Three- and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitors

The Journal of pharmacology and experimental therapeutics, 1999-07, Vol.290 (1), p.429

1999

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1452: Deciphering mechanisms of Ref-1 signaling and its inhibition in aggressive tumor-stroma PDAC models

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1452-1452

2021

Link zum Volltext

Verfügbarkeit prüfen

Effects of Antipsychotic Drugs on Ito, INa, Isus, IK1, and hERG: QT Prolongation, Structure Activity Relationship, and Network Analysis

Pharmaceutical research, 2006-06, Vol.23 (6), p.1133-1143

2006

Link zum Volltext

Verfügbarkeit prüfen

Three-dimensional quantitative structure activity relationship analyses of substrates for CYP2B6

The Journal of pharmacology and experimental therapeutics, 1999-01, Vol.288 (1), p.21

1999

Link zum Volltext

Verfügbarkeit prüfen

Abstract B32: First-in-class Ref-1 redox inhibitors for the multipathway targeting of survival signals for relapsed childhood acute lymphoblastic leukemia

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (20_Supplement), p.B32-B32

2014

Link zum Volltext

Verfügbarkeit prüfen

3-Phenyl-4-hydroxyquinolin-2(1H)-ones: potent and selective antagonists at the strychnine-insensitive glycine site on the N-methyl-D-aspartate receptor complex

Journal of medicinal chemistry, 1992-09, Vol.35 (18), p.3423-3425

1992

Link zum Volltext

Verfügbarkeit prüfen

Three-Dimensional Quantitative Structure-Permeability Relationship Analysis for a Series of Inhibitors of Rhinovirus Replication

Journal of Chemical Information and Computer Sciences, 2001-11, Vol.41 (6), p.1578-1586

2001

Link zum Volltext

Verfügbarkeit prüfen

Experimental Designs for Selecting Molecules from Large Chemical Databases

Journal of Chemical Information and Computer Sciences, 1997-09, Vol.37 (5), p.861-870

1997

Link zum Volltext

Verfügbarkeit prüfen

Use of Conformationally Restricted Benzamidines as Arginine Surrogates in the Design of Platelet GPIIb-IIIa Receptor Antagonists

Journal of medicinal chemistry, 1997-08, Vol.40 (18), p.2843-2857

1997

Link zum Volltext

Verfügbarkeit prüfen

Development of Dual-Acting Agents for Thromboxane Receptor Antagonism and Thromboxane Synthase Inhibition. 3. Synthesis and Biological Activities of Oxazolecarboxamide-Substituted ω-Phenyl-ω-(3-pyridyl)alkenoic Acid Derivatives and Related Compounds

Journal of medicinal chemistry, 1998-12, Vol.41 (27), p.5362-5374

1998

Link zum Volltext

Verfügbarkeit prüfen

A Drug Candidate Design Environment Using Evolutionary Computation

IEEE transactions on evolutionary computation, 2008-10, Vol.12 (5), p.591-603

2008

Link zum Volltext
IEEE_Xplore

Applications of Molecular Diversity Analysis in High Throughput Screening

SLAS discovery, 1997-03, Vol.2 (2), p.65-67

1997

Link zum Volltext

Verfügbarkeit prüfen

1,2-Dibenzamidobenzene Inhibitors of Human Factor Xa

Journal of medicinal chemistry, 2000-03, Vol.43 (5), p.859-872

2000

Link zum Volltext

Verfügbarkeit prüfen

Dibasic benzo[ b]thiophene derivatives as a novel class of active site directed thrombin inhibitors. 2. Exploring interactions at the proximal (S 2) binding site

Bioorganic & medicinal chemistry letters, 1998-09, Vol.8 (18), p.2527-2532

1998

Link zum Volltext

Verfügbarkeit prüfen

Effects of Antipsychotic Drugs on I sub(to), I sub(Na), I sub(sus), I sub(K1), and hERG: QT Prolongation, Structure Activity Relationship, and Network Analysis

Pharmaceutical research, 2006-06, Vol.23 (6), p.1133-1143

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(46)

Sprache

Englisch
(46)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Life Sciences & Biomedicine
(26)
Pharmacology & Pharmacy
(25)
Humans
(18)
Structure-Activity Relationship
(16)
Models, Molecular
(15)
Chemistry
(13)
Biological And Medical Sciences
(12)
Chemistry, Medicinal
(12)
Medical Sciences
(12)
Pharmacology. Drug Treatments
(12)
Physical Sciences
(10)
Animals
(8)
Chemistry, Organic
(7)
In Vitro Techniques
(6)
Binding Sites
(5)
Blood. Blood Coagulation. Reticuloendothelial System
(5)
Catalysis
(5)
Protein Conformation
(5)
Rats
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Identification and Characterization of New Chemical Entities Targeting Apurinic/Apyrimidinic Endonuclease 1 for the Prevention of Chemotherapy-Induced Peripheral Neuropathy

New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types

Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel

Influence of Molecular Structure on Substrate Binding to the Human Organic Cation Transporter, hOCT1

Application of Three-Dimensional Quantitative Structure-Activity Relationships of P-Glycoprotein Inhibitors and Substrates

Three-Dimensional Quantitative Structure-Activity Relationships of Inhibitors of P-Glycoprotein

Progress in predicting human ADME parameters in silico

Biodistribution Study of Dibenzazepine-loaded Polymeric Nanoparticles in Sprague Dawley Rats

Acyl Sulfonamide Anti-Proliferatives: Benzene Substituent Structure−Activity Relationships for a Novel Class of Antitumor Agents

Three-dimensional-quantitative structure activity relationship analysis of cytochrome P-450 3A4 substrates

Three- and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitors

Abstract 1452: Deciphering mechanisms of Ref-1 signaling and its inhibition in aggressive tumor-stroma PDAC models

Effects of Antipsychotic Drugs on Ito, INa, Isus, IK1, and hERG: QT Prolongation, Structure Activity Relationship, and Network Analysis

Three-dimensional quantitative structure activity relationship analyses of substrates for CYP2B6

Abstract B32: First-in-class Ref-1 redox inhibitors for the multipathway targeting of survival signals for relapsed childhood acute lymphoblastic leukemia

3-Phenyl-4-hydroxyquinolin-2(1H)-ones: potent and selective antagonists at the strychnine-insensitive glycine site on the N-methyl-D-aspartate receptor complex

Three-Dimensional Quantitative Structure-Permeability Relationship Analysis for a Series of Inhibitors of Rhinovirus Replication

Experimental Designs for Selecting Molecules from Large Chemical Databases

Use of Conformationally Restricted Benzamidines as Arginine Surrogates in the Design of Platelet GPIIb-IIIa Receptor Antagonists

Development of Dual-Acting Agents for Thromboxane Receptor Antagonism and Thromboxane Synthase Inhibition. 3. Synthesis and Biological Activities of Oxazolecarboxamide-Substituted ω-Phenyl-ω-(3-pyridyl)alkenoic Acid Derivatives and Related Compounds

A Drug Candidate Design Environment Using Evolutionary Computation

Applications of Molecular Diversity Analysis in High Throughput Screening

1,2-Dibenzamidobenzene Inhibitors of Human Factor Xa

Dibasic benzo[ b]thiophene derivatives as a novel class of active site directed thrombin inhibitors. 2. Exploring interactions at the proximal (S 2) binding site

Effects of Antipsychotic Drugs on I sub(to), I sub(Na), I sub(sus), I sub(K1), and hERG: QT Prolongation, Structure Activity Relationship, and Network Analysis

Suchergebnisse filtern